IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Blood Cells, Molecules, and Diseases

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

1.68

h-Index

2024-2025

 100

Rank

2024-2025

 9111

SJR

2024-2025

 0.633

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Blood Cells, Molecules, and Diseases
Abbreviation Blood Cells Mol. Dis.
Publication Type Journal
Subject Area, Categories, Scope Hematology (Q2); Cell Biology (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)
h-index 100
Overall Rank/Ranking 9111
SCImago Journal Rank (SJR) 0.633
Impact Score 1.68
Publisher Academic Press Inc.
Country United States
ISSN 10960961, 10799796
Best Quartile Q2
Coverage History 1995-2025




Aim and Scope


Blood Cells, Molecules & Diseases emphasizes not only blood cells, but also covers the molecular basis of hematologic disease and studies of the diseases themselves. This is an invaluable resource to all those interested in the study of hematology, cell biology, immunology, and human genetics.


About Blood Cells, Molecules, and Diseases


Blood Cells, Molecules, and Diseases is a journal covering the technologies/fields/categories related to Hematology (Q2); Cell Biology (Q3); Molecular Biology (Q3); Molecular Medicine (Q3). It is published by Academic Press Inc.. The overall rank of Blood Cells, Molecules, and Diseases is 9111. According to SCImago Journal Rank (SJR), this journal is ranked 0.633. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 100. The best quartile for this journal is Q2.

The ISSN of Blood Cells, Molecules, and Diseases journal is 10960961, 10799796. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Blood Cells, Molecules, and Diseases is cited by a total of 251 articles during the last 3 years (Preceding 2024).


Blood Cells, Molecules, and Diseases Impact IF 2024-2025


The Impact IF 2024 of Blood Cells, Molecules, and Diseases is 1.68, which is computed in 2025 as per its definition. Blood Cells, Molecules, and Diseases IF is increased by a factor of 0.03 and approximate percentage change is 1.82% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Blood Cells, Molecules, and Diseases Impact IF 2025 Prediction


Impact IF 2024 of Blood Cells, Molecules, and Diseases is 1.68. If the same upward trend persists, Impact IF may rise in 2025 as well.


Impact IF Trend


Year wise Impact IF of Blood Cells, Molecules, and Diseases. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 1.68
2023 1.65
2022 1.79
2021 1.95
2020 2.56
2019 2.07
2018 1.59
2017 1.63
2016 1.89
2015 2.55
2014 2.54

Blood Cells, Molecules, and Diseases h-index


  Table Setting

Blood Cells, Molecules, and Diseases has an h-index of 100. It means 100 articles of this journal have more than 100 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Blood Cells, Molecules, and Diseases ISSN


The ISSN of Blood Cells, Molecules, and Diseases is 10960961, 10799796. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Blood Cells, Molecules, and Diseases Rank and SCImago Journal Rank (SJR)


The overall rank of Blood Cells, Molecules, and Diseases is 9111. According to SCImago Journal Rank (SJR), this journal is ranked 0.633. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Blood Cells, Molecules, and Diseases by Year


Year SJR
2025/2026 Coming Soon
2024 0.633
2023 0.584
2022 0.718
2021 0.720
2020 0.844
2019 0.740
2018 0.696
2017 0.828
2016 0.935
2015 1.287
2014 1.083

Ranking of Blood Cells, Molecules, and Diseases by Year


Year Ranking
2025/2026 Coming Soon
2024 9111
2023 9202
2022 6892
2021 6604
2020 5612
2019 6517
2018 6904
2017 5590
2016 4823
2015 3064
2014 3842

Blood Cells, Molecules, and Diseases Publisher


Table Setting

Blood Cells, Molecules, and Diseases is published by Academic Press Inc.. It's publishing house is located in United States. Coverage history of this journal is as following: 1995-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Blood Cells, Molecules, and Diseases is Blood Cells Mol. Dis.. This abbreviation ('Blood Cells Mol. Dis.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Blood Cells, Molecules, and Diseases


If your research field is/are related to Hematology (Q2); Cell Biology (Q3); Molecular Biology (Q3); Molecular Medicine (Q3), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Blood Cells, Molecules, and Diseases?

Blood Cells, Molecules, and Diseases latest impact IF is 1.68. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 2.56 (2020) and 1.59 (2018), respectively, in the last 11 years. Moreover, its average IS is 1.99 in the previous 11 years.


What's the SCImago Journal Rank (SJR) of the Blood Cells, Molecules, and Diseases?

The Blood Cells, Molecules, and Diseases has an SJR (SCImago Journal Rank) of 0.633, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 1.287 in 2015 and the lowest being 0.584 in 2023. Furthermore, the average SJR of the Blood Cells, Molecules, and Diseases over the previous 11-year period stands at 1.99.


What's the latest h-index of the Blood Cells, Molecules, and Diseases?

The latest h-index of the Blood Cells, Molecules, and Diseases is 100.


Who's the publisher of the Blood Cells, Molecules, and Diseases?

The Blood Cells, Molecules, and Diseases is published by the Academic Press Inc., with its country of publication being the United States.


What's the current ranking of the Blood Cells, Molecules, and Diseases?

The Blood Cells, Molecules, and Diseases is currently ranked 9111 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 3064 in 2015 and its lowest position of 9202 in 2023.


What's the abbreviation or short name for the Blood Cells, Molecules, and Diseases?

The standard ISO4 abbreviation for the Blood Cells, Molecules, and Diseases is Blood Cells Mol. Dis..


Is the "Blood Cells, Molecules, and Diseases" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Blood Cells, Molecules, and Diseases is classified as a journal that the Academic Press Inc. publishes.


What's the scope or major areas of the Blood Cells, Molecules, and Diseases?

The Blood Cells, Molecules, and Diseases encompasses the following areas:

  • Hematology
  • Cell Biology
  • Molecular Biology
  • Molecular Medicine

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Blood Cells, Molecules, and Diseases?

The Blood Cells, Molecules, and Diseases is assigned the following International Standard Serial Numbers (ISSN): 10960961, 10799796.


What's the best quartile of the Blood Cells, Molecules, and Diseases?

The best quartile for the Blood Cells, Molecules, and Diseases is Q2 (2024).


What's the coverage history of the Blood Cells, Molecules, and Diseases?

The Blood Cells, Molecules, and Diseases coverage history can be summarized as follows: 1995-2025.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Academic Ethics journal 8704 Springer Netherlands 34 4.04
Journal of Business Finance and Accounting journal 3244 Wiley-Blackwell Publishing Ltd 96 3.34
Journal of International Financial Management and Accounting journal 1434 Wiley-Blackwell Publishing Ltd 50 10.53
Discourse journal 7536 Routledge 70 2.75
World Englishes journal 7267 Wiley-Blackwell 68 2.38
Marine Biology Research journal 14618 Taylor and Francis Ltd. 47 1.21
Educational Measurement: Issues and Practice journal 6760 Wiley-Blackwell Publishing Ltd 68 1.54
Museum Management and Curatorship journal 10490 Routledge 43 2.06
Asian Textile Journal trade journal 25375 G P S Kwatra 11 0.08
Journal of Immigrant and Refugee Studies journal 7357 Routledge 39 2.17

Check complete list




Year wise Impact Score (IS) of Blood Cells, Molecules, and Diseases

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 1.68
2023 1.65
2022 1.79
2021 1.95
2020 2.56
2019 2.07
2018 1.59
2017 1.63
2016 1.89
2015 2.55
2014 2.54



Top Journals/Conferences in Hematology

Ca-A Cancer Journal for Clinicians
John Wiley and Sons Inc | United States

Annals of Oncology
Elsevier Ltd | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd | United Kingdom

Blood
Elsevier B.V. | United States

Blood Cancer Journal
Springer Nature | United Kingdom

Lancet Haematology,The
Elsevier Ltd | United Kingdom

Blood cancer discovery
NLM (Medline) | United States

Leukemia
Springer Nature | United Kingdom

Experimental Hematology and Oncology
BioMed Central Ltd | United Kingdom

American Journal of Hematology
John Wiley and Sons Inc | United States

See All

Top Journals/Conferences in Cell Biology

Nature Reviews Molecular Cell Biology
Nature Research | United Kingdom

Cancer Cell
Cell Press | United States

Nature Methods
Nature Research | United Kingdom

Cell Metabolism
Cell Press | United States

Cell Stem Cell
Cell Press | United States

Molecular Cell
Cell Press | United States

Cell Research
Springer Nature | United Kingdom

Annual Review of Plant Biology
Annual Reviews Inc. | United States

Nature Cell Biology
Nature Research | United Kingdom

Nature Metabolism
Springer Berlin | Germany

See All

Top Journals/Conferences in Molecular Biology

Nature Reviews Molecular Cell Biology
Nature Research | United Kingdom

Cell
Elsevier B.V. | United States

Nature Medicine
Nature Research | United Kingdom

Nature Methods
Nature Research | United Kingdom

Nature Reviews Genetics
Nature Research | United Kingdom

Nature Reviews Methods Primers
Springer Nature | United Kingdom

Physiological Reviews
American Physiological Society | United States

Cell Metabolism
Cell Press | United States

Journal of Hematology and Oncology
BioMed Central Ltd | United Kingdom

Molecular Cell
Cell Press | United States

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Research | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd | United Kingdom

Pharmacological Reviews
Elsevier Inc. | United States

Genome Medicine
BioMed Central Ltd | United Kingdom

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Molecular Therapy
Cell Press | United States

Experimental and Molecular Medicine
Springer Nature | United Kingdom

Trends in Molecular Medicine
Elsevier Ltd | United Kingdom

EMBO Molecular Medicine
Springer Science and Business Media Deutschland GmbH | United Kingdom

See All